4-1BBL-Armed Oncolytic Herpes Simplex Virus Exerts Antitumor Effects in Pancreatic Ductal Adenocarcinoma
<b>Background:</b> Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant tumor with a notably poor response to therapy due to its immunosuppressive tumor microenvironment (TME) and intrinsic drug resistance. The oncolytic virus (OV) represents a promising therapeutic strategy cap...
Saved in:
| Main Authors: | Wenrui Gao, Zhuoqian Zhao, Ying Bi, Jinghua Li, Na Tian, Cuizhu Zhang, Shuyuan Pan, Li Deng, Yuntao Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/12/12/1309 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances in the Drug Development and Quality Evaluation Principles of Oncolytic Herpes Simplex Virus
by: Basma Eid Abdullah Ghorab, et al.
Published: (2025-04-01) -
circ-1584 selectively promotes the antitumor activity of the oncolytic virus M1 on pancreatic cancer
by: Taofang Hao, et al.
Published: (2025-03-01) -
Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer
by: Feilong Zhou, et al.
Published: (2025-09-01) -
Herpes simplex virus I and II: A therapeutic approach
by: H. van der Plas, et al.
Published: (2011-11-01) -
Herpes Simplex Virus-1 and Bell's Palsy
by: J Gordon Millichap
Published: (2008-05-01)